CA3149221A1 - Procede de recherche d'organismes specifiques chez un individu - Google Patents

Procede de recherche d'organismes specifiques chez un individu Download PDF

Info

Publication number
CA3149221A1
CA3149221A1 CA3149221A CA3149221A CA3149221A1 CA 3149221 A1 CA3149221 A1 CA 3149221A1 CA 3149221 A CA3149221 A CA 3149221A CA 3149221 A CA3149221 A CA 3149221A CA 3149221 A1 CA3149221 A1 CA 3149221A1
Authority
CA
Canada
Prior art keywords
individual
microbiome
patient
clostridium
stool sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3149221A
Other languages
English (en)
Inventor
Sabine HAZAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA3149221A1 publication Critical patent/CA3149221A1/fr
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de recherche d'organismes spécifiques chez un individu, lequel procédé comprend les étapes consistant à: a) dépister l'individu ; b) acquérir un échantillon de selles de l'individu; c) traiter l'échantillon de selles pour obtenir le microbiome de l'individu; d) séquencer le microbiome de l'individu; et e) analyser le microbiome de l'individu pour déterminer si un ou plusieurs organismes spécifiques sont présents chez l'individu, ce qui permet de déterminer un état de santé de l'individu. L'étape de traitement peut comprendre les sous-étapes suivantes i) l'extraction de l'ADN de l'échantillon de selles, laquelle comprend l'ajout de l'échantillon de selles dans un tube à billes d'agitation, la réalisation d'une lyse cellulaire, la capture de l'ADN sur une membrane de silice dans une colonne de centrifugation, et le lavage et l'élution de l'ADN à partir de la membrane ; et ii) la purification de l'ADN extrait. L'invention concerne également un procédé permettant de déterminer si un individu présente un état de santé comprenant les mêmes étapes. L'invention concerne également un kit de collecte d'échantillon de selles.
CA3149221A 2019-08-02 2020-07-31 Procede de recherche d'organismes specifiques chez un individu Pending CA3149221A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962882367P 2019-08-02 2019-08-02
US62/882,367 2019-08-02
US201962892409P 2019-08-27 2019-08-27
US62/892,409 2019-08-27
US202062991190P 2020-03-18 2020-03-18
US62/991,190 2020-03-18
US202063002486P 2020-03-31 2020-03-31
US63/002,486 2020-03-31
PCT/US2020/044605 WO2021026025A2 (fr) 2019-08-02 2020-07-31 Procédé de recherche d'organismes spécifiques chez un individu

Publications (1)

Publication Number Publication Date
CA3149221A1 true CA3149221A1 (fr) 2021-02-11

Family

ID=74503987

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3149221A Pending CA3149221A1 (fr) 2019-08-02 2020-07-31 Procede de recherche d'organismes specifiques chez un individu

Country Status (4)

Country Link
EP (1) EP3994283A4 (fr)
AU (1) AU2020326600A1 (fr)
CA (1) CA3149221A1 (fr)
WO (1) WO2021026025A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114369671A (zh) * 2021-11-25 2022-04-19 上海锐翌生物科技有限公司 风湿性关节炎标志微生物及其应用
CN114410809A (zh) * 2021-12-08 2022-04-29 上海金翌生物科技有限公司 慢传输便秘标志微生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009520957A (ja) * 2005-12-21 2009-05-28 エフ.ホフマン−ラ ロシュ アーゲー 便試料中のヘモグロビンおよびm2−pkを測定することによる結腸直腸癌の評価方法
FR2945545B1 (fr) * 2009-05-14 2011-08-05 Univ Aix Marseille Ii Methode de detection d'adn procaryote extrait d'un echantillon de selles
EP2971127B1 (fr) * 2013-03-14 2018-02-28 University Of Ottawa Procédés de diagnostic et de traitement de maladie intestinale inflammatoire
WO2016164402A1 (fr) * 2015-04-06 2016-10-13 Oklahoma Medical Research Foundation Méthodes de diagnostic et de traitement d'une maladie auto-immune
US20190367904A1 (en) * 2016-11-07 2019-12-05 Zymo Research Corporation Automated method for release of nucleic acids from microbial samples

Also Published As

Publication number Publication date
WO2021026025A3 (fr) 2021-03-18
WO2021026025A2 (fr) 2021-02-11
EP3994283A4 (fr) 2022-10-12
EP3994283A2 (fr) 2022-05-11
AU2020326600A1 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
Molinero et al. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile
Wunderink et al. Advances in the causes and management of community acquired pneumonia in adults
Xun et al. Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profiles
Lin et al. Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder
Fodor et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations
Chen et al. Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease
Redondo et al. A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene
Fromentin et al. Respiratory microbiome in mechanically ventilated patients: a narrative review
Iwai et al. The lung microbiome of Ugandan HIV-infected pneumonia patients is compositionally and functionally distinct from that of San Franciscan patients
Wagner et al. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease
WO2018201514A1 (fr) Application d'un marqueur de tuberculose microbienne dans la préparation d'un réactif destiné à être utilisé dans le diagnostic de la tuberculose
Nylund et al. Semi-automated extraction of microbial DNA from feces for qPCR and phylogenetic microarray analysis
CA3149221A1 (fr) Procede de recherche d'organismes specifiques chez un individu
WO2013012332A1 (fr) Identification des sujets à risque de développer le syndrome de l'intestin irritable
Zhang et al. Sampling strategies for three-dimensional spatial community structures in IBD microbiota research
Myat et al. A prospective study of bloodstream infections among febrile adolescents and adults attending Yangon General Hospital, Yangon, Myanmar
Shi et al. Metagenomic analysis of the salivary microbiota in patients with caries, periodontitis and comorbid diseases
Licker et al. Genotype-phenotype correlation in multiresistant Escherichia coli and Klebsiella pneumoniae strains isolated in Western Romania
Weese et al. The rectal microbiota of cats infected with feline immunodeficiency virus infection and uninfected controls
Zhao et al. Rapid Identification of Drug‐Resistant Tuberculosis Genes Using Direct PCR Amplification and Oxford Nanopore Technology Sequencing
Rodino et al. Status check: next-generation sequencing for infectious-disease diagnostics
Huebinger et al. Variations of the lung microbiome and immune response in mechanically ventilated surgical patients
Harbaoui et al. Genetic heterogeneity and predominance of blaCTX‐M‐15 in cefotaxime‐resistant Enterobacteriaceae isolates colonizing hospitalized children in Tunisia
Klimenko et al. The ability of taxonomic identification of bifidobacteria based on the variable regions of 16S rRNA gene
US20220033881A1 (en) Method of testing for specific organisms in an individual